Announces that James Tartaglia, PhD, a former top R&D and commercial development executive with Sanofi Vaccines, has been appointed to the BioVaxys Board of Directors. Dr. Tartaglia fills a vacancy created by the resignation of Director Anthony Dutton, who has stepped down. BioVaxys Technology Corp. shares C.BIOV are trading -$0.03 at $0.25.
Stocks in play: BioVaxys Technology Corp.
Baystreet.ca - Baystreet - Contributor Content
This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here